Nanopore sequencing solutions for cell and gene therapies
)
Overview
Next-generation sequencing (NGS) is an essential tool across the drug development value chain. However, legacy NGS technologies require fragmentation and amplification steps, erasing critical sample information. Discover how Oxford Nanopore Technologies sequencing overcomes these limitations with direct, PCR-free workflows to reveal the true biology of your samples.
In this brochure, find out how nanopore sequencing can be applied in the development of cell, gene, and RNA therapies to provide the data you need to develop better and safer drugs, whilst reducing risk .
